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SUMMARY
The objective of the present study was to determine the prevalence of the intestinal parasites most commonly found in
immunocompromised patients. A group of 111 individuals with acute lymphoid leukaemia (ALL), chronic myeloid leukaemia (CML),
human immunodeficiency virus (HIV) and other immunocompromised conditions (principally haematological disorders) was selected.
A battery of tests was performed on each individual to identify the presence of parasites (three stool specimens with saline solution
and Lugol both directly and by concentration, culture and special staining). No significant differences were found among the frequencies
of the different parasites with the several types of immunocompromised conditions. The overall frequencies of potentially pathogenic
and opportunistic parasites were 32.4% (36/111) and 9% (10/111) respectively, the most frequently encountered among the latter
being Cryptosporidium sp., Microsporidia spp. and Strongyloides stercoralis.
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INTRODUCTION
Although enteroparasitic infections constitute a serious public health
problem in developing countries with inadequate sanitary conditions,
they are not exclusive to them. Many types of helminths and protozoal
intestinal parasites affect man, provoking a wide range of symptoms
that are generally associated with the gastrointestinal tract and dependent
on demographic, socio-economic, physiological and immunological
factors8.
Patients with some type of immunocompromised condition and those
submitted to immunosuppressive therapy have an increased probability
of acquiring parasitic infections, generally with a high degree of
severity9,17,23,24,25.
The immune response of an immunocompetent host against parasites
is a complex system in which both cellular and humoral defence
mechanisms intervene2. These mechanisms involve the production of
pro-inflammatory cytokines and the presentation of antigens to the T
cells by means of antigen-presenting cells that express class II (MHC-
II) molecules22,27. The intestinal mucosae organised in the Peyer’s patches
and immunoglobulin-secretory plasma cells present important natural
barriers8. Activated B cells also produce and secrete IgA that impedes
the adhesion of extracellular parasites20. Intracellular parasites are
controlled by T helper type I lymphocytes (LT1)2,20.
Patients who present immunocompromised cellular or humoral
responses have qualitative and/or quantitative alterations that impede
them from acting efficiently against the infections, manifested in
deterioration of their general condition.
Parasitic infections that cause auto-limited diarrhoea in
immunocompetent patients may cause profuse diarrhoea in
immunocompromised individuals, generally accompanied by loss of
weight, anorexia, malabsorption syndrome and in some cases fever and
abdominal pain. In such patients, parasites such as Cryptosporidium
parvum, Enterocytozoon bieneusi, Encephalytozoon intestinalis and
Strongyloides stercoralis may disseminate to other organs such as the
bronchia, bile and liver ducts, producing symptomatology specific to
the organ affected5,10,11,12,13,15,25,28.
The parasite Giardia duodenalis affects both immunocompetent
individuals and immunocompromised patients, particularly those with
common variable or congenital hypogammaglobulinaemia and those in
advanced states of AIDS with prolonged diarrhoea1,14,16.
Both Cyclospora cayetanensis and Isospora belli have been
incriminated as causes of prolonged diarrhoea, especially in AIDS
patients, although they are thought to cause auto-limited diarrhoea in
immunocompetent individuals15,18,25.
The intestinal non-opportunistic pathogenic parasites most frequently
encountered in immunocompromised hosts include Entamoeba
histolytica/dispar, Balantidium coli and others, but these produce
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symptomatology similar to that observed in immunocompetent
individuals.
The behaviour of these parasitosis in immunocompromised patients
is currently unknown. A preliminary study was therefore carried out to
determine the prevalence of the enteroparasites most frequently
encountered in these individuals.
MATERIALS AND METHODS
A descriptive prospective cohort study design was used. All samples
analysed in this study were remitted to the Intestinal Parasite Laboratory
at Medical School, Universidad de Antioquia, over a period of 12 months,
a total 111 patients aged 0-70 years old, with confirmed diagnosis of
immunodeficiency or treated with immunosuppressive therapy according
to the diagnostic criteria of the 1994 International Congress of the WHO,
were identified for inclusion in the study. The sample in this study was
not randomised.
All the individuals received information about the study and signed
consent forms authorising their participation or that of their children.
The ethics committee of the University of Antioquia approved the
methodology, considering there to be no risks against the physical well-
being, integrity or right to anonymity of the participants.
A preliminary precoded clinico-epidemiological survey was
performed on all these patients, and three fresh stool specimens were
analysed from each person, both directly and by concentration with saline
solution and Ritchie’s technique. Harada Mori cultures were made for
Strongyloides stercoralis and samples were stained by a modified Ziehl-
Nielsen technique for Cryptosporidium parvum, Isospora belli and
Cyclospora cayetanensis3. Finally, gram chromotrope staining was used
for the diagnosis of microsporidia18,19.
In this study, the intestinal parasites considered to be potentially
pathogenic were Entamoeba histolytica/dispar, Giardia lamblia,
Trichuris trichiuria, Ascaris lumbricoides and hookworms; the
opportunistic intestinal parasites were Cryptosporidium parvum,
Cyclospora cayetanensis, Isospora belli, microsporidia and Strongyloides
stercoralis; and the non-pathogenic parasites were Entamoeba coli,
Endolimax nana and Iodamoeba butschlii4.
The variables analysed included age, sex, occupation, gastrointestinal
symptoms or manifestations, type of parasitosis, multiparasitism and
immunocompromised condition.
STATISTICAL ANALYSIS
Statistical software for Windows was used to determine the relation
between the type of parasitism and immunodeficiency, age, sex and
occupation. The degree of association was determined by means of the
Chi2 test.
RESULTS
All 111 patients were confirmed as being immunocompromised
according to the criteria described in Materials and Methods (Table 1).
Of 111 patients 59 (53.1%) were aged 0-14; 16 (14.2%) aged 15-29; 28
(25.2%) aged 30-49 and 8 (7.2%) aged 50 or over. Males constituted 69
(62.2%) of the study population and females 42 (37.8%). Only one case
of multiparasitism occurred (Table 2). The more common
immunodeficiencies (IDFs) were Acute Lymphoid Leukemia (ALL),
Chronic Myeloid Leukemia (CML) and Human Immunodeficiency Virus
(HIV). However, several other IDFs were encountered, i.e.,
Hypogammaglobulinemia, Common Variable Immunodeficiency, and
several cancers and hematological disorders other than ALL and CML.
Of the 111 immunocompromised patients, 53 (47.7%) did not present
any clinical manifestation associated with the gastrointestinal tract, while
58 (52.3%), presented abdominal pain, diarrhoea or flatulence (Table 1).
It is important to point out that only 5/53 (11.3%) of patients without
associated gastrointestinal manifestations were positive for intestinal
parasites recognised as human pathogens, based on faecal samples.
Symptomatic patients presented a frequency of 29/58 (50.0%).
The faecal contamination index (FCI), calculated using the equation
FCI = (PP+PNP+both)/N x 100%, was 39.0%. This value is very close
to that of the Colombian population in general, i.e., 30-38% (Table 2). It
should be pointed out that opportunistic parasites were not taken into
account in this calculation, since no reference values are available for
the Colombian population.
Table 1
Distribution of the different types of immunocompromised clinical
manifestations related to the gastrointestinal tract, including potentially
pathogenic and opportunistic parasites
Agent Positive Negative Total
+ GIT -GIT + GIT -GIT Nº %
ALL 4 3 10 16 33 29.73
CML 1 0 3 4 8 7.21
HIV 17 2 14 3 36 32.43
Other IDF’s 7 1 2 24 34 30.63
Total 29 6 29 47 111 100.0
ALL = Acute Lymphoid Leukemia; CML = Chronic Myeloid Leukemia; IDF
= Immunodeficiencies; N = absolute number; -GIT = without clinical
manifestations associated to GIT; +GIT = with symptomatology related to GIT
(mainly diarrhoea and/or abdominal pain). In Table 1, patients in whom no
pathogenic parasites were found and those who did not reveal any type of parasite
in faecal material analyses were both considered to be negative.
Table 2
Absolute frequency of the results of coprological analyses in
immunocompromised patients
Faecal results N
Negative 61
Pathogenic Parasites (PP) 20
Non-Pathogenic Parasites (NPP) 15
Both types of Parasites (BP) 6
Opportunistic parasites 10
Total 112
One of the patients was infected with opportunistic parasites as well as a non-
pathogenic organism, so that the total number of coprological records is 112
among the 111 individuals evaluated.
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The frequencies of the parasites most commonly found in
immunocompromised hosts are shown in Table 3. The potentially
pathogenic parasites most frequently encountered were Entamoeba
histolytica/dispar (10.0%) and Giardia lamblia (7.2%).
Although no statistically significant differences were seen between
the different types of immunocompromised condition evaluated with
respect to the presence of intestinal parasites at p ≥ 0.05, a strong
correlation was observed between the presence of parasites and
symptomatology (p < 0.05).
In the study population 32.4% of the patients were positive for
potentially pathogenic parasites. The numbers and percentages of patients
harbouring each species are shown in Table 3.
DISCUSSION
The overall prevalence of the intestinal parasites in the study
population was lower than that reported by different researchers on the
Colombian population, according to the results of the 1980 National
Morbidity Survey7. The percentage distribution of each of the parasite
species was also lower (Table 3).
It is important to point out that the patients with clinical
manifestations related to gastro-intestinal tract among the different groups
of immunocompromised individuals present a higher number of
potentially pathogenic parasites than the asymptomatic patients (Table
1). However, a large proportion of symptomatic patients (29/58) was
negative for potentially pathogenic parasites, which confirms the need
to look for other causes associated with clinical gastrointestinal
manifestations. On the other hand, it should be emphasised that the
selection criteria in this study were such that some of the patients included
had cancers, IDFs and haematological alterations known to produce
gastro-intestinal manifestations, which could also have been due to the
treatments used. It was thus not possible to discriminate in all cases
whether symptomatologies were due to intestinal parasites or the
conditions mentioned.
Among the immunocompromised patients, the presence of potentially
pathogenic parasites was expected to be associated with gastrointestinal
manifestations. However it was found that six of the 53 asymptomatic
patients presented parasitoses that were potentially pathogenic. Three
were positive for Entamoeba histolytica/dispar, suggesting that the
parasite encountered was the non-pathogenic E. dispar, although no
attempt was made to differentiate species in this study.
The nematode Strongyloides stercoralis was present in two
asymptomatic HIV-positive patients. This observation agrees with some
published reports of studies where no relation was seen between S.
stercoralis and prolonged diarrhoea in HIV-positive individuals.
Complications involving this parasite have been associated with
immunosuppressive therapy, especially the use of corticosteroids12,21,24.
It is postulated that the female S. stercoralis possesses receptors for these
drugs that induce its multiplication and development, contributing to its
dissemination to other organs and resulting in severe complications. The
above is especially interesting since it would affect the host-parasite
interaction through mechanisms of pathogenicity and avoidance of the
immune response, as well as the type of immunocompromised condition
displayed by the patient and his/her response to the parasite10.
Some studies have found high prevalences of opportunistic parasites
such as C. parvum in 4-8% of the cases with diarrhoea in HIV+ patients
and 13-45% in AIDS patients17, as well as C. cayetanensis, Isospora
belli and Microsporidium in immunocompromised patients6,17,24,26. An
overall prevalence of opportunistic parasites of 9.0% of the patients was
observed during the present study, the species most frequently
encountered being C. parvum, Strongyloides stercoralis and
Microsporidia sp. Patients who presented microsporidia had CD4+ T
lymphocytes counts of less than 50 cells/mm3
Our results could have been affected by the prophylactic treatment
with albendazol that all patients except HIV+ individuals received as
standard protocol in the different health care centres, before being
remitted to the laboratory (data not shown). However a faecal
contamination index of 39.0% was obtained, indicating that evaluations
should be made more frequently to prevent these infections from
becoming more serious health problems for immunocompromised
patients due to greater susceptibility.
RESUMO
Frequência de parasitas intestinais em pacientes
imunocomprometidos com e sem manifestações gastrointestinais:
estudo preliminar
O objetivo do presente estudo é avaliar a frequência de parasitas
intestinais em pacientes com alterações imunológicas. Foram analisadas
111 pessoas com leucemia linfóide aguda (LLA), leucemia mieloide
crônica, virus da imunodeficiência humana (VIH) e outras doenças,
principalmente alterações sanguíneas. Para cada indivíduo foram
realizados exames seriados de fezes tanto com solução salina quanto
com lugol #3, direto e por concentração, culturas de fezes e colorações
específicas.
Não houve diferenças significativas na frequência de parasitoses nos
distintos grupos avaliados. A frequência de parasitas potencialmente
patogênicos foi de 32.4% (36/111) enquanto a de parasitas oportunistas
foi de 9.0% (10/111). As espécies mais observadas foram C. parvum,
microsporídios spp. e S. stercoralis.
Table 3
Distribution of potentially pathogenic and opportunistic intestinal parasites
Parasite Number %
Entamoeba histolytica/dispar 11 9.91
Giardia lamblia 8 7.21
Strongyloides stercoralis 4 3.60
Trichuris trichiuria 4 3.60
Ascaris lumbricoides 1 0.90
Hookworm 2 1.80
Cryptosporidium parvum 4 3.60
Microsporidia sp. 2 1.80
Total 36/111 32.43
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